• VisionGate Announces an Exclusive Global License, Manufacturing and Supply Agreement for Iloprost, VisionGate’s Phase 2 Oral Lung Cancer Interception Drug

    VisionGate Announces an Exclusive Global License, Manufacturing and Supply Agreement for Iloprost, VisionGate’s Phase 2 Oral Lung Cancer Interception Drug   [...]

    by Intrado Globe Newswire

    August 22,2019

    Diagnostic TestsNew

  • Lung Cancer Prevention Trial Progress and PCI Pharma Services Manufacturing Agreement

    Press Release, January 29, 2019

    by VisionGate

    January 29,2019

    NewsResearch

  • VisionGate, Inc. Appoints R. John Glasspool as Chief Operating and Strategy Officer and member of the Board of Directors

    Press Release, October 11, 2018

    by VisionGate

    October 11,2018

    New

  • Results and Presentation of Important New Research at the 2018 IASLC World Conference on Lung Cancer

    Press Release, September 24, 2018

    by VisionGate

    September 28,2018

    New

  • VisionGate Announces New Appointment to the Board of Directors

    Press Release, June 14, 2018

    by VisionGate

    June 14,2018

    New

  • VisionGate, Inc. Appoints Randal Buness as Chief Financial Officer

    Press Release, April 17, 2018

    by VisionGate

    April 17,2018

    New

  • Cellular Imaging Platform Detects the Presence of Cancer-Associated Cells that have undergone Malignancy Associated Change

    Press Release, April 16, 2018

    by VisionGate

    April 16,2018

    Research

  • VisionGate Lung Cancer 3D Cellular Imaging Research to be Featured as a Late-Breaking Abstract at the AACR Annual Meeting 2018

    Press Release, April 12, 2018

    by VisionGate

    April 12,2018

    NewsResearch

  • VisionGate is Leveraging the Cell-CT™ Platform to Expand Cancer Diagnostics Services

    Press Release, April 5, 2018

    by VisionGate

    April 5,2018

    NewsResearch

  • VisionGate Announces Two New Appointments to the Board of Directors

    Press Release, April 4, 2018

    by VisionGate

    April 4,2018

    New

  • New Research Study Demonstrates Applicability of 3-D Cell-CT™ Imaging and Analysis Platform

    Press Release, December 12, 2017

    by VisionGate

    December 12,2017

    NewsPublicationsResearch

  • Advances in Lung Cancer Early Detection and Treatment at the World Conference on Lung Cancer

    Press Release, October 19, 2017

    by VisionGate

    October 6,2017

    NewsResearch

  • VisionGate® to attend JP Morgan Healthcare Conference

    Please visit our CONTACT page to request a meeting

    by VisionGate

    January 5,2017

    New

  • Blinded Trial Data Could Help Alleviate Worry Over Incidental Lung Nodule Findings

    VisionGate Presents Blinded Trial Data at WCLC 2016

    by VisionGate

    December 16,2016

    NewsResearch

  • 17th World Conference on Lung Cancer: VisionGate Will Present Twice!

    CEO Alan Nelson, PhD, and CMO Javier Zulueta, MD, to Present Two Pivotal Papers in Vienna, Austria on December 5, 2016

    by VisionGate

    November 17,2016

    New

  • VisionGate to speak for the exclusive Piper Jaffray Conference

    CEO Alan Nelson, PhD, to Present at the Lotte New York Palace Hotel on November 29, 2016

    by VisionGate

    November 17,2016

    New

  • VisionGate Hires Renowned Chief Medical Officer Dr. Javier Zulueta

    Dr. Zulueta led the longest ongoing lung cancer screening trial in Europe

    by VisionGate

    June 2,2016

    New

  • LuCED Test and New Drug Therapy to Prevent Lung Cancer

    Demonstrate Promise in National Surveys of Pulmonologists  

    by VisionGate

    June 1,2016

    NewsResearch

  • VisionGate’s Alan Nelson Named Academy of Inventors Fellow

    Nelson Holds 139 Patents for Inventions Related to Early Cancer Detection

    by Shelley Parnell

    April 28,2016

    New

  • VisionGate Receives Strategic Investment from Trinnovate Ventures

    Partnership Tackles Lung Cancer, the No. 1 Cancer Killer Throughout the World

    by VisionGate

    March 16,2016

    New

  • Diagnostics company VisionGate migrates into diagnostics

    Biotech Showcase 2016 Interview: Diagnostics company VisionGate migrates into diagnostics

    by VisionGate

    February 24,2016

    Publicatio

  • VisionGate to Present at Leerink Partners Global Healthcare Conference

    Wednesday, Feb. 10, 2016

    by VisionGate

    February 5,2016

    New

  • Lung Cancer Pioneers Create Lung Cancer Eradication Pact

    Partnership Would Combine Company’s Patented Technology that Detects Pre-cancer of the Lungs with Drug Treatment that Prevents Cancer  

    by VisionGate

    January 7,2016

    Research

  • Phoenix firefighters get free lung-cancer testing

    Phoenix firefighters get free lung-cancer testing

    by VisionGate

    December 4,2015

    New

  • Making LIFE Better

    VisionGate Receives AZBio Fast Lane Honors

    by VisionGate

    September 22,2015

    NewsPublicatio

  • VisionGate’s LuCED Shows Promise for Lung Cancer Screening

    Blinded Trial Results Released at WCLC2015    

    by VisionGate

    September 11,2015

    NewsResearch

  • Significant Lung Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology

    Two newly published articles demonstrate potential for lung cancer screening using sputum      

    by VisionGate

    July 9,2015

    NewsPublicatio

  • World renowned surgeon joins VisionGate’s Medical Advisory Board

    VisionGate welcomes NYU Langone Medical Center's Dr. Harvey Pass

    by VisionGate

    April 1,2015

    New

  • VisionGate Receives Backing From Dignity Health in Arizona

    For Non-Invasive Lung Cancer Testing  

    by VisionGate

    February 3,2015

    New

  • VisionGate® Wins Two Gold Awards in the Best in Biz Awards 2014

    Most Innovative Company of the Year (Small) and Most Innovative Product of the Year (SMB) categories    

    by VisionGate

    December 11,2014

    New

  • VisionGate CEO and President Both Among Arizona’s Top Business Leaders

    VisionGate CEO Alan Nelson, PhD, and President Scarlett Spring Among Arizona's Top Business Leaders

    by VisionGate

    November 24,2014

    New

  • New Data Demonstrates VisionGate’s LuCED® Test Able to Detect Early Cancer

    Early Cancer Detection Even From Small Nodules

    by VisionGate

    November 20,2014

    NewsResearch

  • VisionGate Adds 3 Prominent Directors

    VisionGate Adds 3 Prominent Directors

    by VisionGate

    June 20,2014

    New

  • VisionGate Adds Three Prominent Board Directors

    VisionGate Adds Three Prominent Board Directors

    by VisionGate

    June 5,2014

    New

  • Lung cancer test shows high senstitivity, specificity, and early stage detection

    Lung cancer test shows high sensitivity, specificity, and early stage detection - Medical Device Daily

    by VisionGate

    May 23,2014

    New

  • New Study Shows High Sensitivity and Specificity for LuCED® Test to Help Detect Lung Cancer Earlier

    Data to be Presented at ASCO 2014 Demonstrates that Non-Invasive LuCED Test Detects Stage I and II Lung Cancer       [...]

    by VisionGate

    May 15,2014

    Research

  • VisionGate to Present Early Lung Cancer Detection Data at ASCO

    LuCED® Test Has Potential to Detect Cancer with a Cough

    by VisionGate

    May 7,2014

    New

  • VisionGate featured in Oct 2013 Nature Article

    VisionGate, Inc. was just featured in a Nature article in Oct. 2013. You can also read the article on the Nature website.

    by VisionGate

    November 14,2013

    Publicatio

  • Non-invasive Detection of Lung Cancer from Cells in Sputum Using Cell-CT™

    IASLC 2013 Poster: Non-invasive Detection of Lung Cancer from Cells in Sputum Using Cell-CT™

    by VisionGate

    October 28,2013

    NewsPublicatio

  • VisionGate Presents Clinical Data at IASLC Meeting

    VisionGate Presents Clinical Data at IASLC Meeting Showing its Cell-CT 3D Imaging Platorm detects Lung Cancer with High Sensitivity and Specificity

    by VisionGate

    October 28,2013

    Research

  • Adjunctive use of its 3D cell imaging platform can increase utility of CT screening for Lung Cancer

    IASLC_Press_Release_063011_FINAL_FOR WEBSITE POSTING

    by VisionGate

    October 15,2013

    NewsPublicationsResearch

  • VisionGate Updates

    As VisionGate was preparing for a busy Fall season with the generation of clinical data for lung cancer screening using its LuCED [...]

    by VisionGate

    August 19,2013

    New

  • Dr. Alan Nelson named Research Fellow at International Prevention Research Institute

    Dr. Alan Nelson, CEO of VisionGate, has been recently named a Research Fellow at International Prevention Research Institute. The International Prevention Research [...]

    by VisionGate

    August 7,2013

    New

  • Game Changer for Lung Cancer Announced

    NATIONAL EXPERT PANEL RECOMMENDS ANNUAL CT SCANS FOR THOSE AT HIGH RISK FOR LUNG CANCER; PUBLIC AND PRIVATE REIMBURSEMENTS EXPECTED TO FOLLOW [...]

    by VisionGate

    August 7,2013

    Research

  • VisionGate featured in Nature Magazine

    VisionGate was recently featured in the Nature magazine article about different technologies for early detection for cancer. You can find the article [...]

    by VisionGate

    January 18,2013

    Publicatio

  • VisionGate reports advances in it’s Cell-CT 3D cell analysis platform

    VisionGate reports advances in it's Cell-CT automated 3D cell analysis platform at ASC 2012 Scientific Meeting

    by VisionGate

    January 18,2013

    NewsResearch

  • Medical Device Daily – VisionGate presents at OneMedForum 2012 Conference

    Medical Device Daily - VisionGate presents at OneMedForum 2012 Conference

    by VisionGate

    January 23,2012

    NewsPublicatio

  • $2.6 million NIH grant to achieve full Automation of Cell-CT™ 3D imaging system

    VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer and other applications, today reported that [...]

    by VisionGate

    January 6,2012

    New

  • Financing and collaboration to evaluate its 3D Cell Imaging platform for early lung cancer detection

      VisionGate_Collaborations_Press_Release

    by VisionGate

    October 19,2011

    New

  • Columnar Cell

    The cell is shown in maximum intensity projection. In the center and right panels, color and opacity have been adjusted to render [...]

    by VisionGate

    May 17,2011

    Research

  • Adenocarcinoma

    The cell is shown in maximum intensity projection. In the center and right panels, color and opacity have been adjusted to render [...]

    by VisionGate

    May 17,2011

    Research

  • Cell-CT

    The Cell-CT™ uses a technique called Optical Projection Tomography to render cells in 3D. This process is illustrated in the video where [...]

    by VisionGate

    May 17,2011

    Research

  • Welcome to VisionGate

    VisionGate is dedicated to saving lives through early cancer detection and prevention.  The Cell-CT™ is a revolutionary automated 3D cell imaging platform that [...]

    by VisionGate

    May 12,2011

    New

  • Patients FAQ’s

    Learn more about our LuCED® lung test, VisionGate’s non-invasive diagnostic test to aid physicians in the early detection of lung cancer.

    by VisionGate

    April 24,2011

    Diagnostic TestsResearch

  • Physicians FAQ’s

    The LuCED® lung test is a non-invasive, cost-effective test to precede, supplement or follow low-dose CT scans.

    by VisionGate

    April 23,2011

    Diagnostic TestsResearch

  • Researchers FAQ’s

    VisionGate has ongoing research opportunities and continues to grow its team of collaborative partners from around the world.

    by VisionGate

    April 21,2011

    Diagnostic TestsResearch

  • Diagnostics Pipeline

    VisionGate is developing the sputum-based LuCED test to aid in early detection of lung cancer.

    by VisionGate

    April 12,2011

    Diagnostic TestsResearch

  • LuCED test development at the 24th International Conference for Lung cancer screening

    Getting a Better Look at Lung Nodules: Cell Scan Delivers Images Without X-rays An Interview With Thomas Neumann, MD Author: Anita Shaffer [...]

    by VisionGate

    February 25,2011

    Research

  • VisionGate Recipient of Qualifying Therapeutic Discovery Project Program

    Non-Dilutive Funding for Cancer Screening Test Phoenix, AZ, November 2, 2010 – VisionGate, an Arizona-based biomedical company, was awarded a coveted research [...]

    by VisionGate

    November 2,2010

    New

  • The city of Phoenix is opening the world’s first biomedical 3D cellular imaging lab

    The Cell-CT™ research lab, located on the Phoenix Biomedical Campus in downtown Phoenix, is seeking proposals from researchers in universities and nonprofit organizations to utilize the Cell-CT™ imaging device.

    by VisionGate

    September 10,2010

    Research

  • World’s First Biomedical Cell-CT™ Research Lab to Open

    The City of Phoenix, in partnership with VisionGate, Inc., is opening the world's first biomedical 3D cellular imaging lab. The Cell-CT™ research lab, located on the Phoenix Biomedical Campus in downtown Phoenix, is seeking proposals from researchers in universities and nonprofit organizations to utilize the Cell-CT™ imaging device.

    by VisionGate

    September 10,2010

    New

  • VisionGate, Inc. announced five abstracts describing its Cell-CT™ system for 3D cellular imaging

    VisionGate, Inc. presented abstracts describing its Cell-CT system and the Lung Cell Evaluation Device test (LuCED), for early detection of lung cancer, at [...]

    by VisionGate

    August 24,2010

    NewsResearch

  • VisionGate receives $3 million in government grants

    VisionGate has been officially awarded a three-year, $2.62 million grant from NIH as part of an initiative called Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies (BRDG-SPAN) Program.

    by VisionGate

    June 18,2010

    New

  • Arizona State University’s Biodesign Institute will acquire the first commercially available Cell-CT™ imaging platform

    February 26, 2009 Tempe, AZ – In an effort to advance knowledge of human cell biology to improve human health, Arizona State [...]

    by VisionGate

    February 26,2009

    New

  • VisionGate and Seattle Cancer Care Alliance join forces

    Seattle, WA, December 17, 2008 – VisionGate, Inc. (a local privately held biomed/biotech company) today announced its collaboration with the Seattle Cancer [...]

    by VisionGate

    December 17,2008

    New

  • Peer-reviewed publication in Pattern Recognition demonstrates superiority of Cell-CT™

    Seattle, WA, September 29, 2008 – VisionGate, a privately held biomed/biotech company, today announced the publisher’s notification of acceptance of a study [...]

    by VisionGate

    September 29,2008

    NewsPublicationsResearch

  • Swedish Cancer Institute Taking Part in Development of Cell-CT™ Platform for Lung Cancer Risk Assessment

    Swedish Cancer Institute Taking Part in Clinical Trial of Sputum Test for Early Detection of Lung Cancer SEATTLE, May, 2, 2008 – [...]

    by VisionGate

    May 1,2008

    New